Approval · Notice of Compliance 667 · 2002
DRAXIMAGE MDP+: Notice of Compliance 667
Issued September 20, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 667
- Date
- September 20, 2002
- Company
- Draximage Inc.
- Product type
- Radiopharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing site
- Therapeutic class
- Radiodiagnostic kit
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DRAXIMAGE MDP+ | Not yet assigned | — |
Medicinal ingredients
- MEDRONIC ACID 10 MG per VIAL